SciELO - Scientific Electronic Library Online

 
vol.40 número3Uso de métodos anticoncepcionais de alta eficiência depois da interrupção voluntária da gravidez em Profamilia, 2015-2020 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Facultad Nacional de Salud Pública

versão impressa ISSN 0120-386Xversão On-line ISSN 2256-3334

Resumo

SILVA-AYCAGUER, Luis Carlos  e  BLOCH-SILVA, Andrés. Reflexiones acerca de las cambiantes narrativas sobre las vacunas contra la covid-19. Rev. Fac. Nac. Salud Pública [online]. 2022, vol.40, n.3, e07.  Epub 31-Maio-2023. ISSN 0120-386X.  https://doi.org/10.17533/udea.rfnsp.e349338.

We set out to discern to what extent the media strategies adopted around the vaccines against covid-19 during the first 15 months since the beginning of their application can be considered as a legitimate and coherent contributions to a better understanding about their performance and to what extent the elaborated discourses could respond to the economic interests of the corporations’ elites. Once the most relevant elements that have shaped the predominant narratives from the moment the vaccines were conceived were compiled, several anomalies were identified that were to a greater or lesser extent invisibilized in the process of their approval and the results of their application. The most significant of these concern the handling of definitions, non-compliance with commitments and conflicts of interest that compromise the actions of vaccine marketing companies and regulatory bodies. Many elements related to corporative interests have influenced the narrative concerning vaccines. Among those that require a resignification are: their real preventive capacity against contagions, serious diseases and deaths, their efficacy against new variants, the duration of the immunity they confer, their side effects, the synergic role of acquired immunity, and the resources used by the companies to achieve a virtually market monopolistic predominance.

Palavras-chave : COVID-19 vaccines; Efficacy; Controlled clinical trial; Conflict of interest; Marketing.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )